↓ Skip to main content

Bevacizumab: a new way of doing business. Part 2

Overview of attention for article published in Eye, November 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (53rd percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
6 tweeters
facebook
1 Facebook page

Citations

dimensions_citation
1 Dimensions

Readers on

mendeley
8 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Bevacizumab: a new way of doing business. Part 2
Published in
Eye, November 2018
DOI 10.1038/s41433-018-0281-2
Pubmed ID
Authors

Andrew J. Lotery, Michael A. Burdon

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 8 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 8 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 25%
Student > Ph. D. Student 2 25%
Student > Bachelor 1 13%
Student > Master 1 13%
Researcher 1 13%
Other 1 13%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 1 13%
Biochemistry, Genetics and Molecular Biology 1 13%
Nursing and Health Professions 1 13%
Social Sciences 1 13%
Medicine and Dentistry 1 13%
Other 1 13%
Unknown 2 25%

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 December 2018.
All research outputs
#10,482,278
of 19,015,416 outputs
Outputs from Eye
#1,352
of 3,583 outputs
Outputs of similar age
#184,535
of 408,189 outputs
Outputs of similar age from Eye
#13
of 59 outputs
Altmetric has tracked 19,015,416 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,583 research outputs from this source. They receive a mean Attention Score of 4.6. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 408,189 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.
We're also able to compare this research output to 59 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.